![Why Europe is no longer a value trap](https://i-invdn-com.investing.com/news/LYNXNPEC5Q0S0_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.730 | 2.730 | 0.000 |
Stocks | 97.270 | 97.270 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.632 | 19.779 |
Price to Book | 4.365 | 4.043 |
Price to Sales | 2.291 | 2.422 |
Price to Cash Flow | 17.335 | 16.160 |
Dividend Yield | 1.893 | 1.381 |
5 Years Earnings Growth | 9.817 | 12.141 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.450 | 94.881 |
Consumer Cyclical | 0.550 | 9.926 |
Number of long holdings: 58
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.34 | 844.27 | -3.16% | |
UnitedHealth | US91324P1021 | 4.92 | 523.51 | -1.44% | |
J&J | US4781601046 | 4.83 | 156.15 | -0.70% | |
Thermo Fisher Scientific | US8835561023 | 4.07 | 531.85 | -0.15% | |
AbbVie | US00287Y1091 | 4.03 | 192.87 | -0.30% | |
Novo Nordisk B | DK0062498333 | 3.77 | 557.5 | -1.50% | |
Merck&Co | US58933Y1055 | 3.36 | 83.01 | -1.67% | |
Novartis | CH0012005267 | 3.18 | 95.37 | -2.46% | |
Roche Holding Participation | CH0012032048 | 3.09 | 294.50 | -1.11% | |
AstraZeneca | GB0009895292 | 2.98 | 11,708.0 | -2.14% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S-Asuntorahasto | 463.26M | 5.61 | -6.06 | - | ||
FIM Emerging markets ESG | 382.98M | 0.50 | -0.22 | 3.26 | ||
S SaastOrahasto Kohtuullinen | 326.96M | 2.21 | 4.93 | 5.62 | ||
FIM USA | 312.29M | 3.03 | 13.28 | 12.14 | ||
S-Saastorahasto Rohkea | 307.55M | 2.76 | 7.41 | 7.89 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review